Breaking News, Collaborations & Alliances

Societal CDMO Amends Verapamil PM Product Sales Deal with Lannett

Awarded potential new GMP manufacturing agreements for multiple additional Lannett products.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Societal CDMO, a contract development and manufacturing organization (CDMO) for primarily small molecule development and manufacturing, has signed an amendment to its license and supply agreement with Lannett Company for the marketing of Verapamil PM and Verelan SR products. Societal will now receive improved overall economics, including a 10% increase in the profit share component of revenue from Verapamil PM product sales, as well as immediate and scheduled increases in manufacturing prices. A...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters